-
FASTER, MOSTLY FAITHFUL: CAN AI REPRODUCE MANUAL PICO EXTRACTION IN PREPARATION FOR EU JCA?
Aug 11, 2026, 17:16 PM -
AUTOMATED QUALITY ASSURANCE FOR LLM-ASSISTED EVIDENCE EXTRACTION IN SYSTEMATIC REVIEWS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PEMBROLIZUMAB AS FIRST-LINE TREATMENT FOR METASTATIC NON-SMALL CELL LUNG CANCER WITH HIGH PD-L1 EXPRESSION IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
THE BEST OF BOTH WORLDS? HYBRID PROGRAMMATIC-AI WORKFLOWS FOR HTA-GRADE EVIDENCE GENERATION FOR TIME-TO-EVENT ANALYSIS INTERPRETATION AND REPORTING
Aug 11, 2026, 17:16 PM -
DEVELOPMENT AND CONTENT VALIDATION OF THE FIRST CARETAKER-REPORTED GENERIC HEALTH-RELATED QUALITY OF LIFE (HRQL) INSTRUMENT FOR HORSES
Aug 11, 2026, 17:16 PM -
ONE CONCEPT, MANY COHORTS: IMPACT OF COHORT PHENOTYPE DEFINITIONAL VARIANCE IN DEPRESSION, MAJOR DEPRESSIVE DISORDER AND TREATMENT-RESISTANT DEPRESSION ON REAL-WORLD RESEARCH
Aug 11, 2026, 17:16 PM -
SHORT- AND MID-TERM OUTCOMES OF TEVAR IN DESCENDING THORACIC AORTIC PATHOLOGIES: INSIGHTS FROM A FRENCH NATIONWIDE COHORT
Aug 11, 2026, 17:16 PM -
NEGOTIATED CLOSED BUDGETS AND GENERIC ENTRY IN ORAL ANTICOAGULANTS IN GREECE, 2021-2025: IMPROVING PATIENT ACCESS WHILE CONTAINING PHARMACEUTICAL EXPENDITURE
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPACT OF GENERIC SUBSTITUTION AND INSURANCE DRUG FORMULARY POLICIES ON MEDICATION COVERAGE DECISIONS AND PRESCRIBING IN SAUDI ARABIA PRIVATE HEALTHCARE SECTOR
Aug 11, 2026, 17:16 PM -
TREATMENT SEQUENCING AND LINE-OF-THERAPY PATTERNS IN THE BTKI ERA: REAL-WORLD EVIDENCE FROM 24,410 CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS USING NORSTELLALINQ
Aug 11, 2026, 17:16 PM -
IMPACT OF THE MYCOCARE PATIENT SUPPORT PROGRAM ON THE MANAGEMENT OF PATIENTS WITH PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
Aug 11, 2026, 17:16 PM -
EFFICACY AND SAFETY EVIDENCE ASSOCIATED WITH FIRST-LINE TREATMENTS FOR PATIENTS WITH PD-L1 =50% ADVANCED NSCLC: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
COMPARING PATIENT PERSPECTIVES AND HTA REQUIREMENTS IN HEALTH ECONOMIC MODELING: A MULTIPLE SCLEROSIS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REAL-WORLD UTILIZATION, EXPENDITURES, AND CARDIOVASCULAR EVENTS AMONG USERS OF SGLT-2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS IN US ADULTS WITH TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM -
DO CHILDREN AGREE WITH CAREGIVERS ON PERCEIVED HEALTH? EXPLORING DISCREPANCIES BETWEEN SELF-REPORTED AND PROXY-REPORTED HEALTH STATUS IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT ANALYSIS OF EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT FOR SEVERE SYMPTOMATIC TRICUSPID REGURGITATION FROM THE FRENCH HEALTHCARE PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
TUMOR STABILIZATION AND LONG-TERM IGF-1 NORMALIZATION RATE WITH PASIREOTIDE LAR AND PEGVISOMANT IN REAL-WORLD SECOND-LINE ACROMEGALY TREATMENT
Aug 11, 2026, 17:16 PM -
WHICH GOALS CAN WE MEASURE? THE EVALUABILITY OF EU HTA REGULATION OBJECTIVES
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF FLURBIPROFEN VERSUS LOXOPROFEN SODIUM CATAPLASMS IN KNEE OSTEOARTHRITIS: EVIDENCE FROM A PHYSICIAN-PHARMACIST COLLABORATIVE RANDOMIZED TRIAL
Aug 11, 2026, 17:16 PM -
GENDER GAP IN MEDICINE AFFORDABILITY - NATIONWIDE EVIDENCE FROM FINLAND
Aug 11, 2026, 17:16 PM
